Lexaria Bioscience Corp (LEXX) Total Assets by Year
Lexaria Bioscience Corp closed fiscal year 2025 with $4.2M in total assets, $1.6M in total liabilities and $3.0M in shareholder equity. This represents a decrease of 52.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lexaria Bioscience Corp has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LEXX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.2M-52.9% | $8.9M+187.5% | $3.1M-60.6% | $7.8M-41.0% | $13.3M+369.1% | $2.8M+5.7% | $2.7M+10.0% | $2.4M-15.0% | $2.9M+404.8% | $567K-20.4% | $712K-73.0% | $2.6M-26.3% | $3.6M-14.8% | $4.2M-3.4% | $4.3M |
| Total Liabilities | $1.6M+30.1% | $1.2M+199.3% | $404K+100.5% | $201K-0.9% | $203K-41.2% | $346K+87.5% | $185K+322.8% | $44K-52.7% | $92K-69.3% | $301K+445.3% | $55K-94.0% | $918K-37.7% | $1.5M-16.7% | $1.8M+5.5% | $1.7M |
| Total Equity | $3.0M-62.8% | $8.0M+164.0% | $3.0M-61.7% | $7.9M-39.2% | $13.1M+426.3% | $2.5M-0.3% | $2.5M+4.3% | $2.4M-13.7% | $2.8M+940.4% | $266K-65.6% | $772K-55.0% | $1.7M-18.2% | $2.1M-13.3% | $2.4M-9.0% | $2.7M |
LEXX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.8M-29.1% | $6.5M-25.2% | $6.1M-38.2% | $4.2M-52.9% | $6.7M-32.7% | $8.7M+36.6% | $9.8M+170.0% | $8.9M+187.5% | $10.0M+91.2% | $6.4M+30.8% | $3.6M-41.6% | $3.1M-60.6% |
| Total Liabilities | $437K-72.2% | $277K-85.5% | $1.5M+282.1% | $1.6M+30.1% | $1.6M+480.3% | $1.9M+838.7% | $400K+57.3% | $1.2M+199.3% | $271K-77.4% | $204K-8.5% | $254K-9.8% | $404K+100.5% |
| Total Equity | $4.7M-14.7% | $6.6M-7.6% | $4.9M-49.7% | $3.0M-62.8% | $5.6M-45.2% | $7.1M+9.6% | $9.8M+161.2% | $8.0M+164.0% | $10.1M+130.3% | $6.5M+31.1% | $3.7M-40.2% | $3.0M-61.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Lexaria Bioscience Corp financials
Frequently Asked Questions
What was Lexaria Bioscience Corp's total assets in fiscal year 2025?
Lexaria Bioscience Corp closed fiscal year 2025 with $4.2M in total assets, $1.6M in total liabilities and $3.0M in shareholder equity.
How fast is Lexaria Bioscience Corp's total assets growing?
Lexaria Bioscience Corp (LEXX) total assets fell by 52.9% year over year, from $8.9M to $4.2M in fiscal year 2025.
How has Lexaria Bioscience Corp's total assets changed over the years?
Across the 15 fiscal years this page covers, Lexaria Bioscience Corp (LEXX) total assets went from $4.3M in fiscal year 2011 to $4.2M in fiscal year 2025.
What was Lexaria Bioscience Corp's total assets in the most recent quarter?
Lexaria Bioscience Corp (LEXX) reported $4.8M in total assets in Q3 2026. This represents a decrease of 29.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Lexaria Bioscience Corp (LEXX) reported on that line in every period on record.